Delivery Order SPE2DB22D2103-SPE2DB24FS0AD

Award Date 9/25/24
Potential Completion Date 9/26/24
Potential Value $5.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $3,025.61 delivery order contract to AmerisourceBergen Drug Corp for the supply of Focalin XR 20 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has a firm fixed-price pricing type and an...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,016,523 units of the pharmaceutical product Focalin XR 15 mg capsules. The contract has a ceiling value of $3,880.28 and a period of performance through March 20, 2024. This delivery order appears to be issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp,...
The Defense Logistics Agency (DLA) awarded a $2,362.12 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4564616924 - FOCALIN XR 10 MG CAPSULE 100S. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Focalin XR 30 mg capsules. The firm-fixed-price contract has a ceiling value of $1,795.20 and an ultimate completion date of June 27, 2025. This contract is not designated as a set-aside and is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a $5,593.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,566,038,309 units of the pharmaceutical product Focalin XR Capsules 20mg. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,274.92 to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company, for the provision of 4564069060 FOCALIN XR 30 MG CAPSULE 100S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corporation, a wholly-owned subsidiary of Amerisourcebergen Corporation. The $8,507.77 contract is for the delivery of Focalin XR 30 mg capsules to support military treatment programs and facilities. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corporation, with a potential value of $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,029,746 units of FOCALIN XR 25 MG CAPSULE 100S. The contract has a ceiling value of $4,921.00 and a period of performance through March 21, 2024. This delivery order is placed under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued at up to $999,999,999.00 through December...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,200 units of Focalin XR 20 mg capsules to support military treatment programs and facilities. The contract has a ceiling value of $2,048.57 and a period of performance through April 9, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 10 mg Focalin XR capsules. The $2,743.61 contract has a completion date of May 28, 2025 and is not set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support military healthcare...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB24FS0AD
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $5,423.54 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,977,902 units of Focalin XR 40 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion by September 26, 2024.

Generated 12/25/24, 9:21 AM